Umecrine Cognition AB
Developing novel drugs for neurological disorders caused by neuroinflammation.
Yleiskatsaus
- 1–4
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2006
- Perustettu
Avainpäättäjät
Viktor Drvota
CEO
Magnus Doverskog
Chief Executive Officer
Pernilla Sandwall
COO (Chief Operating Officer)
Thomas P. Blackburn
Non-executive Director
+6 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Umecrine Cognition AB is a biotechnology company focused on developing novel treatments for neurological disorders in the brain. Their primary scientific focus is on GABAA receptor modulating steroid antagonists. They aim to treat cognitive disorders caused by neuroinflammation resulting from a wide...